26th Oct 2015 14:50
(ShareCast News) - The FTSE 250 decelerated gradually over the course of Monday's trading, finishing the session down 0.36% at 17,178.66. TalkTalk continued its decline after last week's revelations of a major cyber-attack rumbled on since the weekend. Analysts have calculated that the cyberattack c
Read more12th Oct 2015 15:11
(ShareCast News) - London's mid-cap index was down 0.6% to 16,990.42 at 1545 BST, in line with the broader market as investors struggled for direction amid an absence of market-moving news. Shares in Carillion surged after the construction and support services group expressed confidence over its ful
Read more30th Jul 2015 18:34
(ShareCast News) - Shares in Indivior were given a downgraded 'neutral' rating from Citi after their strong performance in the year to date, while Deutsche Bank argued the company's drug pipeline was not fully reflected in valuation and upgraded to 'buy'. A day after the company's interim results, C
Read more30th Jul 2015 15:05
(ShareCast News) - Shares in Indivior were given a downgraded 'neutral' rating from Citi after their strong performance in the year to date, while Deutsche Bank argued the company's drug pipeline was not fully reflected in valuation and upgraded to 'buy'. A day after the company's interim results, C
Read more29th Jul 2015 10:37
(ShareCast News) - Although half-year sales and earnings declined at Indivior, the speciality pharmaceuticals business demerged from Reckitt Benckiser, they were generally in line with the market forecasts and were followed by improved guidance for the full year. A 10% fall in net sales to $517m cam
Read more5th May 2015 16:47
Underwhelming results from banking heavyweight HSBC offset a late rally in the mining sector on Tuesday, with UK stock markets dropping into the red by the close. The FTSE 100, which rose to a high of 7,053.18 early on, finished down 58.37 points (-0.84%) at 6,927.58. This was the index's lowest clo
Read more5th May 2015 14:03
Pharmaceutical company Indivior reported a drop in first-quarter net revenue but impressed with results of trials for its new treatment for schizophrenia. The company - which was spun off by Reckitt Benckiser late last year - posted operating profit of $115m, down 30% from $165m in the same period l
Read more5th May 2015 13:22
Indivior topped the risers despite pre-tax profit dipping in the first quarter, as its RBP-7000 schizophrenia drug met the primary and secondary endpoints in its phase 3 trial. Just Eat was making gains as it unveiled strong first quarter results, where like-for-like orders grew 47%. Miners includ
Read more